Matthew T. Wiley - Chief Commercial Officer at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
BTAI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Matthew T. Wiley - trading volume in the past year for BioXcel Therapeutics, Inc.

Holdings reported by Matthew T. Wiley for BioXcel Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 8,250 $10.4 K $1.26 Jun 15, 2024 Direct Common Stock
Common Stock 3,498 $4.42 K $1.26 Jun 17, 2024 Direct

Transactions reported by Matthew T. Wiley for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership